LFBC(SZ:002513) Ge Long Hui A P P·2026-01-27 09:57Core Viewpoint - Bluefeng Biochemical (002513.SZ) expects a net profit loss attributable to shareholders of the listed company between 230 million and 150 million yuan for the year 2025, with a similar range for net profit after deducting non-recurring gains and losses [1] Group 1: Performance Forecast - The company anticipates a net profit loss of 230 million to 150 million yuan for the year 2025 [1] - The expected loss after deducting non-recurring gains and losses is also projected to be between 230 million and 150 million yuan [1] Group 2: Reasons for Performance Changes - The company and its subsidiaries conducted a comprehensive review of various assets at the end of the reporting period, leading to the recognition of asset impairment provisions due to signs of impairment, which reduced the net profit attributable to shareholders by approximately 64.16 million yuan [1] - The agricultural chemical segment continues to incur losses due to a significant increase in raw material prices while the sales prices of main products have been declining [1] - Although the new energy segment has reduced production costs through technological upgrades, it still faces low product prices due to industry competition, resulting in a significant decrease in the loss margin year-on-year, but the profitability has not met expectations [1]